ZA200900957B - Use of tenecteplase for treating acute ischemic stroke - Google Patents
Use of tenecteplase for treating acute ischemic strokeInfo
- Publication number
- ZA200900957B ZA200900957B ZA200900957A ZA200900957A ZA200900957B ZA 200900957 B ZA200900957 B ZA 200900957B ZA 200900957 A ZA200900957 A ZA 200900957A ZA 200900957 A ZA200900957 A ZA 200900957A ZA 200900957 B ZA200900957 B ZA 200900957B
- Authority
- ZA
- South Africa
- Prior art keywords
- tenecteplase
- ischemic stroke
- treating acute
- acute ischemic
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82386806P | 2006-08-29 | 2006-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900957B true ZA200900957B (en) | 2010-05-26 |
Family
ID=38835003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900957A ZA200900957B (en) | 2006-08-29 | 2007-08-01 | Use of tenecteplase for treating acute ischemic stroke |
Country Status (22)
Country | Link |
---|---|
US (2) | US20080107641A1 (no) |
EP (1) | EP2056856B1 (no) |
JP (1) | JP5785687B2 (no) |
KR (1) | KR20090045405A (no) |
CN (1) | CN101505785A (no) |
AU (1) | AU2007290277B2 (no) |
BR (1) | BRPI0716143A2 (no) |
CA (1) | CA2661012C (no) |
CO (1) | CO6150188A2 (no) |
EA (1) | EA015573B1 (no) |
EC (1) | ECSP099178A (no) |
HK (1) | HK1131054A1 (no) |
IL (2) | IL196987A (no) |
MX (1) | MX2009001918A (no) |
MY (1) | MY163119A (no) |
NO (1) | NO342302B1 (no) |
NZ (1) | NZ574767A (no) |
SG (3) | SG174753A1 (no) |
TW (1) | TWI439282B (no) |
UA (1) | UA97486C2 (no) |
WO (1) | WO2008027687A2 (no) |
ZA (1) | ZA200900957B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
EP2540696B1 (en) | 2005-02-24 | 2020-01-01 | Diffusion Pharmaceuticals LLC | Trans carotenoids, formulation and uses |
AU2007290277B2 (en) | 2006-08-29 | 2013-04-11 | Genentech, Inc. | Use of tenecteplase for treating acute ischemic stroke |
KR101570131B1 (ko) | 2007-04-13 | 2015-11-18 | 디퓨젼 파마슈티컬즈 엘엘씨 | 양극성 트랜스 카로티노이드의 말초혈관질환 치료와 예방을 위한 용도 |
US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US20110257510A1 (en) * | 2008-12-24 | 2011-10-20 | Koninklijke Philips Electronics N.V. | System, method and apparatus for cardiac intervention with mr stroke detection and treatment |
EP2445339B1 (en) | 2009-06-22 | 2019-08-07 | Diffusion Pharmaceuticals LLC | Diffusion enhancing compound and its use with a thrombolytic |
US10555915B2 (en) | 2009-08-24 | 2020-02-11 | Hough Ear Institute | Methods for treating acute acoustic trauma |
CN105287473A (zh) | 2010-06-02 | 2016-02-03 | 扩散药品有限公司 | 包含双极性反式类胡萝卜素的组合物及其应用 |
BR112013015914B1 (pt) * | 2010-12-23 | 2021-06-08 | Gennova Biopharmaceuticals Ltd. | composições farmacêuticas de tenecteplase |
WO2014062888A1 (en) * | 2012-10-18 | 2014-04-24 | University Of South Florida | Compositions and methods for treating stroke |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
US8715315B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment systems |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
CN109730806B (zh) | 2013-03-15 | 2023-01-24 | 伊瑟拉医疗公司 | 脉管治疗装置和方法 |
WO2015023830A1 (en) | 2013-08-14 | 2015-02-19 | Stc.Unm | Treatment and prevention of stroke and other neurological disorders |
ES2829923T3 (es) * | 2014-10-21 | 2021-06-02 | Gennova Biopharmaceuticals Ltd | Un proceso novedoso de purificación para el aislamiento y la producción comercial de tnk-tpa recombinante (tenecteplase) |
CN108697423A (zh) | 2016-02-16 | 2018-10-23 | 伊瑟拉医疗公司 | 抽吸装置和锚定的分流装置 |
WO2017165667A1 (en) | 2016-03-24 | 2017-09-28 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
CA3050858A1 (en) * | 2017-01-24 | 2018-08-02 | Ekos Corporation | Method for the treatment of thromboembolism |
WO2018210860A1 (en) * | 2017-05-16 | 2018-11-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of acute ischemic stroke |
US10426424B2 (en) | 2017-11-21 | 2019-10-01 | General Electric Company | System and method for generating and performing imaging protocol simulations |
WO2021158799A1 (en) * | 2020-02-04 | 2021-08-12 | The Regents Of The University Of Colorado, A Body Corporate | Prophylactic uses of annexin a2 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
AU664469B2 (en) | 1992-06-03 | 1995-11-16 | Genentech Inc. | Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
JP2002173447A (ja) * | 2000-09-29 | 2002-06-21 | Yamanouchi Pharmaceut Co Ltd | 脳塞栓症治療用医薬組成物 |
US7084118B2 (en) * | 2002-02-22 | 2006-08-01 | Genentech, Inc. | Combination treatment with t-PA variant and low molecular weight heparin |
US20030180282A1 (en) * | 2002-03-25 | 2003-09-25 | Victor Serebruany | Method of treatment of thrombotic events |
US20070014779A1 (en) * | 2002-11-14 | 2007-01-18 | Genentech, Inc. | Plasminogen activator variant formulations |
WO2006094120A2 (en) * | 2005-03-02 | 2006-09-08 | The Regents Of The University Of California | Treatment for embolic stroke |
AU2007290277B2 (en) | 2006-08-29 | 2013-04-11 | Genentech, Inc. | Use of tenecteplase for treating acute ischemic stroke |
-
2007
- 2007-08-01 AU AU2007290277A patent/AU2007290277B2/en active Active
- 2007-08-01 UA UAA200902855A patent/UA97486C2/ru unknown
- 2007-08-01 MX MX2009001918A patent/MX2009001918A/es active IP Right Grant
- 2007-08-01 MY MYPI20090793A patent/MY163119A/en unknown
- 2007-08-01 BR BRPI0716143-3A patent/BRPI0716143A2/pt not_active Application Discontinuation
- 2007-08-01 JP JP2009526788A patent/JP5785687B2/ja active Active
- 2007-08-01 NZ NZ574767A patent/NZ574767A/en unknown
- 2007-08-01 WO PCT/US2007/074997 patent/WO2008027687A2/en active Application Filing
- 2007-08-01 ZA ZA200900957A patent/ZA200900957B/xx unknown
- 2007-08-01 US US11/832,291 patent/US20080107641A1/en not_active Abandoned
- 2007-08-01 TW TW096128284A patent/TWI439282B/zh active
- 2007-08-01 CA CA2661012A patent/CA2661012C/en not_active Expired - Fee Related
- 2007-08-01 EP EP07840638.6A patent/EP2056856B1/en active Active
- 2007-08-01 KR KR1020097006363A patent/KR20090045405A/ko active Search and Examination
- 2007-08-01 CN CNA2007800318116A patent/CN101505785A/zh active Pending
- 2007-08-01 SG SG2011062213A patent/SG174753A1/en unknown
- 2007-08-01 SG SG10201804944XA patent/SG10201804944XA/en unknown
- 2007-08-01 SG SG10201501498VA patent/SG10201501498VA/en unknown
- 2007-08-01 EA EA200970237A patent/EA015573B1/ru unknown
-
2009
- 2009-02-09 IL IL196987A patent/IL196987A/en active IP Right Grant
- 2009-02-27 CO CO09020350A patent/CO6150188A2/es unknown
- 2009-03-12 EC EC2009009178A patent/ECSP099178A/es unknown
- 2009-03-27 NO NO20091296A patent/NO342302B1/no unknown
- 2009-11-12 HK HK09110542.3A patent/HK1131054A1/xx unknown
-
2011
- 2011-07-22 US US13/189,413 patent/US9023346B2/en active Active
-
2016
- 2016-10-05 IL IL248176A patent/IL248176A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201501498VA (en) | Use of tenecteplase for treating acute ischemic stroke | |
IL194113A (en) | Combinations of stroke treatment materials | |
EP2034830A4 (en) | PROCESS FOR TREATMENT OF STROKE | |
IL193460A0 (en) | Compounds and methods for treatment of stroke | |
EP2330302A4 (en) | CYLINDER APPARATUS | |
ZA201004859B (en) | Use of a gamma-secretase inhibitor for treating cancer | |
EP1996182A4 (en) | CANCER TREATMENT WITH GAMMA SECRETASE INHIBITORS | |
IL193639A0 (en) | Collagenase for treating cellulite | |
EP2264308A4 (en) | PLASMA DEVICE WITH CYLINDER HEAD | |
EP2047976A4 (en) | STEEL PLATE REINFORCING MATERIAL OF ANY KIND WHICH GIVES VIBRATION DAMPING PERFORMANCE TO A STEEL PLATE | |
EP2325529A4 (en) | ZYLINDERKOPFDICHTUNG | |
EP2078522A4 (en) | COMPOSITION FOR THE TREATMENT OF ALLERGIES | |
GB2457583B (en) | Paint-metering cylinder | |
GB0815766D0 (en) | Rotary piston and cylinder devices | |
EP2131030A4 (en) | CYLINDER BLOCK | |
IL212212A0 (en) | Compound useful for treating cellulite | |
EP2249765A4 (en) | DAPSONE TO TREAT THE ROSACEA | |
GB2453625B (en) | Keys for cylinder assemblies | |
ZA200807221B (en) | Collagenase for treating cellulite | |
EP2306051A4 (en) | CYLINDER SEAL | |
HK1119755A1 (en) | Brake cylinder | |
IL201328A0 (en) | Cylinder lock | |
TWI368170B (en) | Interruption-based concurrent profiling method | |
GB0817784D0 (en) | Hydraulic cylinder and related arrangements | |
GB2453626B (en) | Keys for cylinder assemblies |